Effect of tofogliflozin on cardiac and vascular endothelial function in patients with type 2 diabetes and heart diseases: A pilot study

Recent studies have shown that sodium–glucose cotransporter 2 inhibitors decrease the risk of heart failure in patients with type 2 diabetes. However, the precise mechanisms of action of these drugs are not well understood. In the present study, we evaluated the effect of treatment with tofogliflozi...

Descripción completa

Detalles Bibliográficos
Autores principales: Tochiya, Mayu, Makino, Hisashi, Tamanaha, Tamiko, Matsuo, Miki, Hishida, Ai, Koezuka, Ryo, Ohata, Yoko, Tomita, Tsutomu, Son, Choel, Miyamoto, Yoshihiro, Yasuda, Satoshi, Hosoda, Kiminori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078080/
https://www.ncbi.nlm.nih.gov/pubmed/31361403
http://dx.doi.org/10.1111/jdi.13122

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078080/
https://www.ncbi.nlm.nih.gov/pubmed/31361403
http://dx.doi.org/10.1111/jdi.13122

Ejemplares similares